Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.68 |
| ▸ | MEN1 | O00255 | 4/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.68 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.68 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.68 |
| ▸ | IGF1R | P08069 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10746494 | 0.91 | GAA (0.82) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL2796836 | 0.91 | GAA (0.82) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL18704990 | 0.86 | KMT2A (0.73) | GAAKMT2AMEN1KDM4EOPRM1 | |
| Acetic Acid SCHEMBL9325415 | 0.86 | GAA (0.75) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL352281 | 0.86 | GAA (1.00) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL3976521 | 0.85 | GAA (0.74) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL4466517 | 0.85 | KMT2A (0.71) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL4474689 | 0.85 | KMT2A (0.71) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL4477437 | 0.85 | KMT2A (0.71) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL4486265 | 0.85 | KMT2A (0.71) | GAAKMT2AMEN1KDM4EOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022204065-A1 | IRON(III) MACROCYCLIC COMPLEXES WITH MIXED HYROXYL PENDANTS AS MRI CONTRAST AGENTS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2022-09-29 | — | — | WO | disclosed |